X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
care and treatment (2) 2
hematology (2) 2
index medicus (2) 2
multicenter (2) 2
oncology (2) 2
transplantation (2) 2
abridged index medicus (1) 1
aged (1) 1
allogeneic (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
bacterial (1) 1
bone marrow (1) 1
bortezomib (1) 1
bortezomib - administration & dosage (1) 1
bortezomib - therapeutic use (1) 1
clinical trial (1) 1
clinical-trials (1) 1
complications and side effects (1) 1
consensus development project (1) 1
corticosteroids (1) 1
criteria (1) 1
cytomegalovirus infections (1) 1
death (1) 1
diagnosis (1) 1
disease-free survival (1) 1
dosage and administration (1) 1
everolimus (1) 1
experience (1) 1
female (1) 1
gvhd (1) 1
hematopoietic stem cells (1) 1
humans (1) 1
immunology (1) 1
incidence (1) 1
infection (1) 1
lymphoma, non-hodgkin - drug therapy (1) 1
lymphoma, non-hodgkin - mortality (1) 1
male (1) 1
malignancies (1) 1
multiple-myeloma (1) 1
non-hodgkin lymphoma (1) 1
non-hodgkin's lymphomas (1) 1
non‐hodgkin lymphoma (1) 1
phase 2 (1) 1
proteasome inhibitor bortezomib (1) 1
ruxolitinib (1) 1
single-agent temsirolimus (1) 1
sirolimus - administration & dosage (1) 1
sirolimus - analogs & derivatives (1) 1
sirolimus - therapeutic use (1) 1
steroid-refractory (1) 1
temsirolimus (1) 1
therapy (1) 1
transplant (1) 1
trial (1) 1
wisconsin (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3440 - 3440
Background: Tyrosine kinase inhibitor (TKI) therapy has led to phenomenal improvement in overall survival for patients with CML. Since TKI therapies were... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3837 - 3837
Background: Outcomes of patients with AML have remained poor despite the availability of cytotoxic chemotherapy, hypomethylating agents (HMAs) and targeted... 
Journal Article
Leukemia Research, ISSN 0145-2126, 05/2019, Volume 80, pp. 40 - 42
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5843 - 5843
Abstract Introduction: The development of tyrosine kinase inhibitors (TKIs) has markedly improved the prognosis of patients (pts) with chronic myeloid leukemia... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 5192 - 5192
Abstract Introduction: The outcome of adult patients with relapsed/refractory ALL remains dismal. In pediatric patients with relapsed/refractory ALL, the... 
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.